Liabilities / Assets
25th percentile
Higher debt load relative to assets than 25% of similar nonprofits.
990 • Fiscal year 2021 • EIN 59-3432665
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
25th percentile
Higher debt load relative to assets than 25% of similar nonprofits.
Liabilities / Revenue
78th percentile
Higher debt load relative to revenue than 78% of similar nonprofits.
Net Margin
26th percentile
Higher net margin than 26% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
24th percentile
Faster asset growth than 24% of similar nonprofits.
Revenue Growth
2nd percentile
Faster revenue growth than 2% of similar nonprofits.
Assets
Up$9,156,713
Up $2,606 (+0.0%) from 2020
Net Assets
Up$8,969,193
Up $7,339 (+0.1%) from 2020
Liabilities
Down$187,520
Down $4,733 (-2.5%) from 2020
Revenue
Down$284,326
Down $887,810 (-76%) from 2020
Expenses
Down$281,359
Down $21,871 (-7.2%) from 2020
Net Income
Down$2,967
Down $865,939 (-100%) from 2020
Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Land, Buildings, and Equipment, Net | $4,701,684 | $5,876,274 | ▲ $1,174,590 |
| Cash and Non-Interest-Bearing Accounts | $4,447,763 | $3,280,439 | ▼ $1,167,324 |
| Loans From Officers Directors | $155,488 | $154,516 | ▼ $972 |
| Investments in Publicly Traded Securities | $4,660 | - | - |
| Total Assets | $9,154,107 | $9,156,713 | ▲ $2,606 |
| Liabilities | |||
| Other Liabilities | $36,765 | $33,004 | ▼ $3,761 |
| Total Liabilities | $192,253 | $187,520 | ▼ $4,733 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $8,961,854 | $8,969,193 | ▲ $7,339 |
| Total Net Assets Fund Balance | $8,961,854 | $8,969,193 | ▲ $7,339 |
| Total Liabilities and Net Assets / Fund Balance | $9,154,107 | $9,156,713 | ▲ $2,606 |
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Buildings | $2,669,434 | $619,171 | $3,288,605 |
| Land | $3,229,805 | - | $3,229,805 |
| Other Land Buildings | $13,169 | $374,660 | $387,829 |
| Name | Title | Full / Part Time | Base | Total |
|---|---|---|---|---|
| Siamak Tabibzadeh Md | CEO | FT | $88,000 | $88,000 |
| Name | Title |
|---|---|
| Shila Roofim | CFO |
| Forough Sooferian | Sec |
| Line Item | Amount |
|---|---|
| Salaries, Compensation, and Employee Benefits | $150,853 |
| Other Expenses | $130,506 |
| Total Fundraising Expense | $9,463 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Comp Disqual Persons | $70,400 | $8,800 | $8,800 | $88,000 |
| Depreciation Depletion | $50,206 | - | - | $50,206 |
| Other Salaries and Wages | $50,000 | - | - | $50,000 |
| All Other Expenses | $6,435 | $6,880 | - | $13,315 |
| Payroll Taxes | $9,267 | $663 | $663 | $10,593 |
| Other Expenses | $6,142 | $17,519 | - | $6,142 |
| Insurance | $4,031 | - | - | $4,031 |
| Fees for Services Accounting | $3,350 | - | - | $3,350 |
| Other Employee Benefits | $2,260 | - | - | $2,260 |
| Fees for Services Legal | - | $500 | - | $500 |
| Total Functional Expenses | $237,534 | $34,362 | $9,463 | $281,359 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Line Item | Beginning | End | Change |
|---|---|---|---|
| Loans from Officers, Directors, Trustees, and Key Employees | $155,488 | $154,516 | ▼ $972 |
| Liability | Amount |
|---|---|
| Tenant Deposits | $16,890 |
| Officer Related Liability | $12,925 |
| Credit Card/ Payroll Taxes | $3,189 |
“No review was or will be conducted.”
“No documents available to the public”
“Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.”
“See attachment november 20, 2022 part iv, line 63, loans from officers, director and employee on november 20, 2002, frontiers in bioscience, inc. Purchased for investment purposes only residential real estate located at 67 parkview drive, searingtown, new york. In connection with the organization's purchase of said real estate, frontiers in bioscience inc., incurred a mortgage payable with the presiden and founder, siamak tabibzadeh, md, in the amount of 145,000 lender's name: siamak tabibzadeh, md original amount of note: 154,000 balance due: 145,555 date of note: november 20, 2002 maturity date: open, see below repayment terms: principal and accrued interest due upon sale of property interest rete: rate of 4.5% per annum, principal and interest due upon sale of property or at such time as the board of director determines that there are sufficient operating funds to retire the obiligation security priovided by the borrower: mortgage note secured by real estate located at 67 parkview drive, searingtown, ny 11507 purpose of the loan: to be able to purchase real estate at below fair market value to see in no longer than two operating cycles in order to obtain sufficient funding to endow a full time medical researcher and editor. Interst calcuation original amount of principal: 154,000 from to interest amount (rate, 4.5%) - principal + interest nov 20, 2002 154,000 nov 20, 2002 nov 20, 2003 6,930 - 160,930 - 15,375 removed principal & interest leaving 145,555 nov 20, 2003 nov 20, 2004 6,549 - 152,104 nov 20, 2004 nov 20, 2005 6,844 - 158,948 nov 20, 2005 nov 20, 2006 7,152 - 166,100 nov 20, 2006 nov 20, 2007 7,474 - 173,574 nov 20, 2007 nov 20, 2008 7,810 - 181,384 nov 20, 2008 nov 20, 2009 8,162 - 189,546 nov 20, 2009 nov 20, 2010 8,529 - 198,075 nov 20, 2010 nov 20, 2011 8,913 - 206,988 nov 20, 2011 nov 20, 2012 9,314 - 216,302 nov 20, 2012 nov 20, 2013 9,733 - 226,035 nov 20, 2013 nov 20, 2014 10,171 - 236,206 nov 20, 2014 nov 20, 2015 10,629 - 257,942 nov 20, 2015 nov 20, 2016 11,107 - 246,835 nov 20, 2016 nov 20, 2017 11,607 - 269,549 principal paid 269,549-145,555=123,994 nov 20, 2017 nov 20, 2018 5,579 - 129,573 nov 20, 2018 nov 20, 2019 5,830 - 135,403 nov 20, 2019 nov 20, 2020 6,093 - 141,496 nov 20, 2020 nov 20, 2021 6,367 - 147,863 nov 20, 2021 nov 20, 2022 6,653 - 154.516”
“Adjustment to beginning of value of investments -14160”
“Book / tax depreciation difference 18,532”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt | 0 | 6880 |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 6435 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 13315 |
| IRS990/BackupWthldComplianceInd | 0 | false |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 9497158286 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92657 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | false |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 4447763 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 3280439 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompDisqualPersonsGrp/FundraisingAmt | 0 | 8800 |
| IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt | 0 | 8800 |
| IRS990/CompDisqualPersonsGrp/ProgramServicesAmt | 0 | 70400 |
| IRS990/CompDisqualPersonsGrp/TotalAmt | 0 | 88000 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | false |
| IRS990/CompensationProcessOtherInd | 0 | false |
| IRS990/ConflictOfInterestPolicyInd | 0 | false |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 0 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | -23239 |
| IRS990/CYOtherExpensesAmt | 0 | 130506 |
| IRS990/CYOtherRevenueAmt | 0 | 20776 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 286789 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | 2967 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 150853 |
| IRS990/CYTotalExpensesAmt | 0 | 281359 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 9463 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 284326 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/DepreciationDepletionGrp/ProgramServicesAmt | 0 | 50206 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 50206 |
| IRS990/Desc | 0 | FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | false |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 3 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | true |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 237534 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt | 0 | 3350 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 3350 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 500 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 500 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 60.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | SHILA ROOFIM |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | FOROUGH SOOFERIAN |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 88000 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | CEO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | CFO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | SEC |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | false |
| IRS990/Form990TFiledInd | 0 | true |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GainOrLossGrp/SecuritiesAmt | 0 | -31667 |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 3 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt | 0 | 294886 |
| IRS990/GrossReceiptsAmt | 0 | 751491 |
| IRS990/GrossRentsGrp/RealAmt | 0 | 161388 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 0 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIInd | 0 | X |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 4031 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 4031 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 8428 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 8428 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/InvestmentsPubTradedSecGrp/BOYAmt | 0 | 4660 |
| IRS990/IRPDocumentCnt | 0 | 0 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 1029965 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 4701684 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 5876274 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 6906239 |
| IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt | 0 | 326553 |
| IRS990/LessRentalExpensesGrp/RealAmt | 0 | 140612 |
| IRS990/LoanOutstandingInd | 0 | true |
| IRS990/LoansFromOfficersDirectorsGrp/BOYAmt | 0 | 155488 |
| IRS990/LoansFromOfficersDirectorsGrp/EOYAmt | 0 | 154516 |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 8961854 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 8969193 |
| IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt | 0 | -31667 |
| IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt | 0 | -31667 |
| IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt | 0 | 20776 |
| IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt | 0 | 20776 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 8961854 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 8969193 |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherChangesInNetAssetsAmt | 0 | 4372 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 2260 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 2260 |
| IRS990/OtherExpensesGrp/Desc | 0 | LAB SUPPLIES AND FEES |
| IRS990/OtherExpensesGrp/Desc | 1 | UTILITIES |
| IRS990/OtherExpensesGrp/Desc | 2 | HOA DUES |
| IRS990/OtherExpensesGrp/Desc | 3 | TELEPHONE |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 0 | 17519 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 28417 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 7026 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 6142 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 28417 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 17519 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 7026 |
| IRS990/OtherExpensesGrp/TotalAmt | 3 | 6142 |
| IRS990/OtherLiabilitiesGrp/BOYAmt | 0 | 36765 |
| IRS990/OtherLiabilitiesGrp/EOYAmt | 0 | 33004 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 50000 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 50000 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PayrollTaxesGrp/FundraisingAmt | 0 | 663 |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 663 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 9267 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 10593 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrincipalOfficerNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProgramServiceRevenueGrp/BusinessCd | 0 | 541700 |
| IRS990/ProgramServiceRevenueGrp/Desc | 0 | PRODUCTS |
| IRS990/ProgramServiceRevenueGrp/Desc | 1 | SUBSCRIPTION FEES |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 200305 |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 1 | 86484 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 0 | 200305 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 1 | 86484 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYInvestmentIncomeAmt | 0 | 807064 |
| IRS990/PYOtherExpensesAmt | 0 | 150122 |
| IRS990/PYOtherRevenueAmt | 0 | 69365 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 295707 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | 868906 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 153108 |
| IRS990/PYTotalExpensesAmt | 0 | 303230 |
| IRS990/PYTotalRevenueAmt | 0 | 1172136 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | 2967 |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/RentalIncomeOrLossGrp/RealAmt | 0 | 20776 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | true |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | true |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt | 0 | 8428 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 8428 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 8428 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 286789 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 286789 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 8428 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 8428 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.03000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus1YearAmt | 0 | 17915 |
| IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt | 0 | 17915 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.91590 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 286789 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 286789 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 286789 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 295217 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 17915 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 313132 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt | 0 | 200305 |
| IRS990/ScheduleBRequiredInd | 0 | false |
| IRS990ScheduleD/BuildingsGrp/BookValueAmt | 0 | 2669434 |
| IRS990ScheduleD/BuildingsGrp/DepreciationAmt | 0 | 619171 |
| IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 3288605 |
| IRS990ScheduleD/LandGrp/BookValueAmt | 0 | 3229805 |
| IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt | 0 | 3229805 |
| IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt | 0 | 13169 |
| IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt | 0 | 374660 |
| IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 387829 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 0 | 16890 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 1 | 12925 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 2 | 3189 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 0 | TENANT DEPOSITS |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 1 | OFFICER RELATED LIABILITY |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 2 | CREDIT CARD/ PAYROLL TAXES |
| IRS990ScheduleD/TotalBookValueLandBuildingsAmt | 0 | 5912408 |
| IRS990ScheduleD/TotalLiabilityAmt | 0 | 33004 |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt | 0 | 154516 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd | 0 | true |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt | 0 | TO AID THE ORGAN TO ACQUIRED INVEST |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd | 0 | X |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt | 0 | 154000 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt | 0 | DIRECTOR |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd | 0 | true |
| IRS990ScheduleL/TotalBalanceDueAmt | 0 | 154516 |
| IRS990/ScheduleORequiredInd | 0 | false |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154.516 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | NO REVIEW WAS OR WILL BE CONDUCTED. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | NO DOCUMENTS AVAILABLE TO THE PUBLIC |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | ADJUSTMENT TO BEGINNING OF VALUE OF INVESTMENTS -14160 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | BOOK / TAX DEPRECIATION DIFFERENCE 18,532 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PART XI |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990, PART XI, LINE 9 |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990/SubjectToExcsTaxNetInvstIncInd | 0 | false |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/SubjToTaxRmnrtnExPrchtPymtInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | false |
| IRS990/TotalAssetsBOYAmt | 0 | 9154107 |
| IRS990/TotalAssetsEOYAmt | 0 | 9156713 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 9154107 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 9156713 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalEmployeeCnt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 9463 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 34362 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 237534 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 281359 |
| IRS990/TotalGrossUBIAmt | 0 | 20776 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 192253 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 187520 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 192253 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 187520 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 8961854 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 8969193 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 237534 |
| IRS990/TotalProgramServiceRevenueAmt | 0 | 286789 |
| IRS990/TotalReportableCompFromOrgAmt | 0 | 88000 |
| IRS990/TotalRevenueGrp/ExclusionAmt | 0 | 8428 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 255122 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 284326 |
| IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt | 0 | 20776 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 9154107 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 9156713 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | true |
| IRS990/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/USAddress/ZIPCd | 0 | 92657 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 3 |
| IRS990/VotingMembersIndependentCnt | 0 | 0 |
| IRS990/WebsiteAddressTxt | 0 | WWW.BIOSCIENCE.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | false |
| ReturnHeader/BuildTS | 0 | 2022-09-23 18:48:47Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CEO |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 9497158286 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2022-09-02 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | FRONTIERS IN BIOSCIENCE |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | FRON |
| ReturnHeader/Filer/EIN | 0 | 593432665 |
| ReturnHeader/Filer/PhoneNum | 0 | 9497158286 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | NEWPORT COAST |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92657 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 330990695 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | LGH CONSULTING INC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 585 S STATE COLLEGE BLVD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ANAHEIM |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 928064222 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 7148089170 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2022-09-23 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | GEORGE HUKRIEDE |
| ReturnHeader/ReturnTs | 0 | 2022-09-23T17:04:24-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | SIAMAK |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | TABIBZADEH |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2021-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2021-12-31 |
| ReturnHeader/TaxYr | 0 | 2021 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2021 • Form 990Detailed filing. Detailed filing data is available for this year.